Verve Therapeutics had a revenue of 13.08M in the quarter ending Dec 31, 2024, with 90.53%. This bring the company's revenue in the last twelve months to 32.33M, Decreased 32.53%. In the fiscal year ending Dec 31, 2024, Verve Therapeutics had annual revenue of 32.33M with 174.98% growth.